High-fat Diet Promotes Atherosclerosis Through the Microecological-immunological Axis
DOI:
https://doi.org/10.54097/w7akek81Keywords:
Component, High-fat Die, Gut Flora, Metabolites, Cardiovascular DiseaseAbstract
Cardiovascular and cerebrovascular diseases (CVDs) have become one of the leading causes of death in China. Atherosclerosis (AS) is the common pathological basis, and intestinal flora dysbiosis and its metabolites are deeply involved in the development of AS through the "microecology-immunity axis". High-fat diet leads to imbalance of flora structure, decrease of beneficial bacteria and increase of pathogenic bacteria, damage the intestinal barrier, promote the entry of endotoxins (e.g., LPS) and harmful metabolites (e.g., TMAO, lmP, PAGIn, BCAAs) into the bloodstream, activate immune-inflammation (e.g., NF-KB, NLRP3 pathway), platelet activation and thrombosis, and disrupt the lipid metabolism. Reduction of protective metabolites (e.g., SCFAs) impairs anti-inflammatory and endothelial protective effects. Current intervention studies have shifted from traditional flora regulation to targeting metabolites and signaling pathways (e.g., ADR, FXR, I1R inhibition) and exploring multimodal therapies, such as exercise and traditional Chinese medicine. In the future, this article focus on individualized precision intervention, multi-target synergistic strategy, drug delivery system and reliable biomarker validation to promote the clinical translation of AS prevention and treatment.
Downloads
References
[1] Zou, Y., Song, X., Liu, N., Sun, W., & Liu, B. (2022). Intestinal Flora: A Potential New Regulator of Cardiovascular Disease. Aging and disease, 13(3), 753–772. https://doi.org/ 10. 14336/AD.2021.1022.
[2] Luo, Y. T., Cheng, R. Y., Liang, H. J., Wang, J. N., Shen, X., & He, F. (2020). Effects of high-fat diet on glucose and lipid metabolism and gut microbiota structure in mice. Acta Nutrimenta Sinica, *42*(5), 458–464. https://doi.org/10. 13325/ j. cnki.acta.nutr.sin.2020.05.007.
[3] Liu, H., Zhu, H., Xia, H., Yang, X., Yang, L., Wang, S., et al. (2021). Different effects of high-fat diets rich in different oils on lipids metabolism, oxidative stress and gut microbiota. Food research international (Ottawa, Ont.), 141, 110078. https://doi.org/10.1016/j.foodres.2020.110078.
[4] Wan, Y., Wang, F., Yuan, J., Li, J., Jiang, D., Zhang, J., et al. (2019). Effects of dietary fat on gut microbiota and faecal metabolites, and their relationship with cardiometabolic risk factors: a 6-month randomised controlled-feeding trial. Gut, 68(8), 1417–1429. https://doi.org/10.1136/gutjnl-2018-317609.
[5] Jia, X., Xu, W., Zhang, L., Li, X., Wang, R., & Wu, S. (2021). Impact of Gut Microbiota and Microbiota-Related Metabolites on Hyperlipidemia. Frontiers in cellular and infection microbiology, 11, 634780. https://doi.org/10. 3389/ fcimb. 2021.634780.
[6] Qian, Y., Feng, Y. M., Wang, Y. J., Yin, J. Z., & Mi, F. (2022). Research progress on the relationship between gut microbiota and chronic diseases. Chinese Journal of Microecology, *34*(10), 1217–1221. https://doi.org/10. 13381/ j. cnki. cjm. 202210020.
[7] Brandsma, E., Kloosterhuis, N. J., Koster, M., Dekker, D. C., Gijbels, M. J. J., van der Velden, S., et al. (2019). A Proinflammatory Gut Microbiota Increases Systemic Inflammation and Accelerates Atherosclerosis. Circulation research, 124(1), 94–100. https://doi.org/10. 1161/ CIRCRESAHA. 118.313234.
[8] Wen, Y., Sun, Z., Xie, S., Hu, Z., Lan, Q., Sun, Y., et al. (2022). Intestinal Flora Derived Metabolites Affect the Occurrence and Development of Cardiovascular Disease. Journal of multidisciplinary healthcare, 15, 2591–2603. https:// doi. org/10.2147/JMDH.S367591.
[9] Nageswaran, V., Carreras, A., Reinshagen, L., Beck, K. R., Steinfeldt, J., Henricsson, M., et al. (2025). Gut Microbial Metabolite Imidazole Propionate Impairs Endothelial Cell Function and Promotes the Development of Atherosclerosis. Arteriosclerosis, thrombosis, and vascular biology, 45(5), 823–839. https://doi.org/10.1161/ATVBAHA.124.322346.
[10] Mastrangelo, A., Robles-Vera, I., Mañanes, D., Galán, M., Femenía-Muiña, M., Redondo-Urzainqui, A., et al. (2025). Imidazole propionate is a driver and therapeutic target in atherosclerosis. Nature, 645(8079), 254–261. https://doi.org/10. 1038/s41586-025-09263-w.
[11] Niinisalo, P., Oksala, N., Levula, M., Pelto-Huikko, M., Järvinen, O., Salenius, J. P., et al. (2010). Activation of indoleamine 2,3-dioxygenase-induced tryptophan degradation in advanced atherosclerotic plaques: Tampere vascular study. Annals of medicine, 42(1), 55–63. https://doi.org/10.3109/ 07853890903321559.
[12] Nemet, I., Saha, P. P., Gupta, N., Zhu, W., Romano, K. A., Skye, S. M., et al. (2020). A Cardiovascular Disease-Linked Gut Microbial Metabolite Acts via Adrenergic Receptors. Cell, 180(5), 862–877.e22. https://doi.org/10. 1016/j.cell. 2020.02. 016.
[13] Zaric, B. L., Radovanovic, J. N., Gluvic, Z., Stewart, A. J., Essack, M., Motwalli, O., et al. (2020). Atherosclerosis Linked to Aberrant Amino Acid Metabolism and Immunosuppressive Amino Acid Catabolizing Enzymes. Frontiers in immunology, 11, 551758. https://doi.org/10. 3389/ fimmu. 2020.551758.
[14] Chen, J., Xiao, Y., Li, D., Zhang, S., Wu, Y., Zhang, Q., et al. (2023). New insights into the mechanisms of high-fat diet mediated gut microbiota in chronic diseases. iMeta, 2(1), e69. https://doi.org/10.1002/imt2.69.
[15] Chajadine, M., Laurans, L., Radecke, T., Mouttoulingam, N., Al-Rifai, R., Bacquer, E., et al. (2024). Harnessing intestinal tryptophan catabolism to relieve atherosclerosis in mice. Nature communications, 15(1), 6390. https://doi.org/ 10. 1038/ s41467-024-50807-x.
Downloads
Published
Issue
Section
License
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
